Tumor suppressor WWOX and p53 alterations and drug resistance in glioblastomas

Tumor suppressor p53 are frequently mutated in glioblastomas (GBMs) and appears to contribute, in part, to resistance to temozolomide and therapeutic drugs. WW domain-containing oxidoreductase WWOX (FOR or WOX1) is a proapoptotic protein and is considered as a tumor suppressor. Loss of WWOX gene exp...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Ming-Fu eChiang, Pei-Yi eChou, Wan-Jen eWang, Chun-I eSze, Nan-Shan eChang
Format: Artigo
Langue:Inglês
Publié: Frontiers Media S.A. 2013-03-01
Collection:Frontiers in Oncology
Sujets:
p53
tumor suppressor
Glioblastoma Multiforme
WWOX
temozolomide resistance
Accès en ligne:http://journal.frontiersin.org/Journal/10.3389/fonc.2013.00043/full
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires